FDA Grants Orphan Drug Status to Pulmonary Arterial Hypertension Treatment
ZMA001, in development for pulmonary arterial hypertension, has been designated as an Orphan Drug by the US Food and Drug Administration.
Category: Pulmonary Hypertension
Pulmonary Hypertension
Latest
Pulmonary Hypertension
Latest
Complications for Balloon Technique for CTEPH Patients Decrease Significantly
A Michigan Medicine-led study reveals that the once-feared severe complications that occur during balloon pulmonary angioplasty have dropped in recent years.
Pulmonary Hypertension
Latest
Treating Chronic Hypertension in Early Pregnancy Benefits Parents, Infants
Adults treated with medication for chronic hypertension present before or during the first 20 weeks of pregnancy had fewer adverse pregnancy outcomes compared to adults who did not receive antihypertensive treatment.
CVS Offers New Care Management Program for Pulmonary Arterial Hypertension
A CVS subsidiary launched a program to help patients with pulmonary arterial hypertension (PAH) better manage their own care.
Read More
Pulmonary Hypertension May Raise Kidney Failure Risk For Certain Patients
Patients who have chronic kidney disease and pulmonary hypertension are at a greater risk for a variety of adverse outcomes, according to new research.
Read MoreStudy: Iron Supplements and Pulmonary Arterial Hypertension
Can patients with pulmonary arterial hypertension and iron deficiency benefit from iron supplements?
Read More
Study: Surgery Outcomes for Segmental Chronic Thromboembolic Pulmonary Hypertension
A new study, presented at the American Association for Thoracic Surgery’s annual meeting, found that patients treated surgically for segmental chronic thromboembolic pulmonary hypertension had positive outcomes.
Read More
Beta Blockers May Contribute to Insomnia, Sleep Disturbances
New research from the American Heart Association revealed beta-blockers were not more likely to cause depression compared to other similar treatments, but the drugs may be linked to unusual dreams, insomnia and sleep disorders.
Read MoreJanssen Submits NDA for Uptravi IV to Treat Pulmonary Arterial Hypertension
Janssen Pharmaceutical Companies has submitted Uptravi (selexipag) as an injection for intravenous use for the treatment of pulmonary arterial hypertension.
Read More
Pulmonary Hypertension Patients Exhibited Reduced Exercise Capacity Under Hypoxia
Results of a clinical trial show that patients with pulmonary hypertension (PH) have a lower capacity for exercise during hypoxia.
Read More
Study Evaluates The Benefits of Inhaled Nitric Oxide in Pulmonary Hypertension
High dose inhaled nitric oxide resulted in improvements in physical activity and other outcomes in patients at risk for pulmonary hypertension-associated fibrotic interstitial lung disease.
Read More
Study: Diagnosing Pulmonary Hypertension Due to Left Heart Disease
In certain patients, measurements of pulmonary artery (PA) distensibility are more effective at detecting pulmonary hypertension due to left heart disease than measurements of PA dilatation.
Read More
Very Few Pulmonary Hypertension Patients Given Pulmonary Rehabilitation
Among 111,356 veterans with pulmonary hypertension, only 1,737 (1.6%) patients received pulmonary rehabilitation.
Read More
Home Care: First COVID-19 Patient with Pulmonary Hypertension Treated with New iNO System
The patient was treated under an emergency IND filed by a qualified Investigator and approved by the US FDA, according to the manufacturer Vero Biotech.
Read More
Pulmonary Hypertension Implant Gets FDA Breakthrough Tag
The implantable Aria CV Pulmonary Hypertension System has received a breakthrough device designation from the FDA, according to the manufacturer Aria CV.
Read More